Introduction to Ergomed

Ergomed is a premier global contract research organization (CRO) that has established itself as a trusted partner in the healthcare and pharmaceutical industries. Headquartered in Guildford, United Kingdom, Ergomed specializes in providing comprehensive clinical research services, including clinical trial management, pharmacovigilance, and regulatory affairs. With a strong presence across Europe, North America, and Asia, the company employs over 2,000 professionals and serves a diverse clientele ranging from small biotech startups to top-tier pharmaceutical giants. Ergomed's reputation is built on its commitment to scientific excellence, operational efficiency, and patient-centric approaches. The company is recognized for its expertise in oncology, rare diseases, and central nervous system disorders, making it a sought-after partner for complex clinical trials. By leveraging advanced technologies and a global network of clinical sites, Ergomed consistently delivers high-quality results that meet rigorous regulatory standards. Its market reputation as a top Healthcare company is underscored by numerous awards and high customer satisfaction ratings, positioning it as a leader in the CRO space.

Company History and Business Evolution

Ergomed was founded in 1997 by Dr. Nick Woolfson and a team of experienced clinical research professionals with a vision to provide specialized CRO services to the pharmaceutical industry. The company started in the United Kingdom, focusing initially on pharmacovigilance and drug safety, a niche that soon expanded into full-service clinical development. In its early years, Ergomed gained recognition for its agility and deep scientific expertise, quickly securing contracts with mid-sized pharmaceutical companies. A major milestone came in 2005 when Ergomed opened its first international office in Germany, marking the beginning of its European expansion. Subsequent years saw the acquisition of several specialist providers, including a US-based oncology CRO in 2010 and a European rare disease consultancy in 2015. In 2020, Ergomed launched its innovative eClinical platform, integrating digital data capture and remote monitoring capabilities. The company went public on the London Stock Exchange's AIM market in 2015, raising capital to fuel further growth. However, in 2022, Ergomed was acquired by private equity firm Nordic Capital, which delisted the company to support long-term strategic investments. Today, Ergomed continues to evolve, investing heavily in artificial intelligence for clinical trial optimization and expanding its footprint in emerging markets such as China and Latin America. The business evolution reflects a consistent drive towards innovation and client-centricity, enabling Ergomed to maintain a competitive edge in the rapidly changing healthcare landscape.

Ergomed at a Glance

Here are 20 key facts about Ergomed that highlight its scale and capabilities:

• Headquarters: Guildford, United Kingdom
• Founded: 1997
• CEO (as of 2025): Dr. Kees de Wit
• Revenue: Approximately £200 million (latest annual report)
• Employees: Over 2,000 globally
• Industry: Healthcare / Contract Research Organization (CRO)
• Stock Symbol: Previously AIM: EGRD (delisted in 2022)
• Key Services: Clinical Trial Management, Pharmacovigilance, Regulatory Affairs, Medical Writing
• Therapeutic Focus: Oncology, Rare Diseases, CNS, Cardiovascular, Infectious Diseases
• Global Presence: Offices in 10 countries including USA, UK, Germany, France, Spain, Italy, Poland, China, Japan
• Clinical Trials Completed: Over 500
• Average Trial Duration: 3-5 years
• Patient Enrollments: Over 100,000 patients enrolled to date
• Technology: Proprietary eClinical platform, AI-driven data analytics
• Quality Certifications: ISO 9001, ISO 27001, GCP compliant
• Partnerships: Collaborates with major pharma like Pfizer, Novartis, and Roche
• Awards: Multiple ‘Best CRO’ awards from Life Sciences industry bodies
• Community Engagement: Supports patient advocacy groups and rare disease foundations
• Employee Satisfaction: 4.2/5 on Glassdoor (2024)
• Innovation: Patent-pending remote monitoring technology launched 2023

Mission, Vision, and Core Corporate Values

Ergomed's mission is to accelerate the development of life-saving therapies by providing exceptional clinical research services that uphold the highest standards of scientific integrity and patient safety. The company envisions a world where every patient has access to innovative treatments through efficient and ethical clinical trials. Core corporate values include: Integrity – ensuring transparency and honesty in all operations; Collaboration – working closely with sponsors, investigators, and patients; Excellence – delivering high-quality results through continuous improvement; Compassion – prioritizing patient well-being and diversity in clinical trials; and Innovation – embracing technology to streamline processes. These values are embedded in every project and are reflected in Ergomed's robust compliance framework and employee training programs.

Business Strategy and Future Roadmap

Ergomed's business strategy focuses on three pillars: therapeutic specialization, technological innovation, and global expansion. The company concentrates on complex therapeutic areas such as oncology and rare diseases where it can offer deep scientific expertise and differentiated services. Investments in digital tools like AI-powered patient recruitment and real-world data analytics are central to improving trial efficiency and reducing costs. Ergomed also plans to expand in high-growth markets in Asia and Latin America through strategic partnerships and local acquisitions. The future roadmap includes the development of a decentralized clinical trial (DCT) platform, enabling remote patient monitoring and virtual site visits. By 2030, Ergomed aims to increase its market share in the CRO industry by 15% while maintaining high customer loyalty scores. The company is also committed to sustainability, targeting carbon-neutral operations by 2025 through green energy initiatives and supply chain optimization.

Products, Technologies, and Services

Ergomed offers a comprehensive suite of services tailored to the pharmaceutical, biotechnology, and medical device industries. Its core offerings include:

• Clinical Trial Management: Full-service management covering phase I-IV studies, including protocol design, site selection, patient enrollment, monitoring, and data management.
• Pharmacovigilance: Drug safety surveillance including adverse event reporting, signal detection, and risk management plans. Ergomed's pharmacovigilance team handles over 100,000 cases annually.
• Regulatory Affairs: Assistance with regulatory submissions to health authorities such as FDA, EMA, and PMDA, including IND/NDA filing support.
• Medical Writing: Preparation of clinical study reports, investigator brochures, and labeling documents.
• Biostatistics and Data Management: Advanced statistical analysis using SAS and R, with secure data capture via electronic case report forms (eCRFs).
• Technology Solutions: eClinical platform includes CTMS, EDC, and interactive response technology (IRT) for randomization and trial supply management.
• Centralized Monitoring: Risk-based monitoring approach using real-time dashboards and analytics.
• Real-World Evidence: Observational studies and registry development to support post-marketing requirements.

These services are underpinned by a robust quality management system that ensures compliance with ICH GCP guidelines and regulatory standards.

Industries and Markets Served

Ergomed primarily serves the pharmaceutical and biotechnology industries, but also works with medical device companies, contract research organizations, and academic research centers. The company's therapeutic expertise spans oncology, rare diseases, neuroscience, cardiovascular medicine, infectious diseases, and immunology. Geographically, Ergomed has a strong presence in Europe (UK, Germany, France, Italy, Spain, Poland), North America (USA, Canada), and Asia (China, Japan, South Korea). The company is particularly active in emerging markets where clinical trial activity is growing rapidly due to lower costs and diverse patient populations. Ergomed's client base includes top 20 global pharma companies, mid-sized specialty pharma, and innovative biotech firms. The company also partners with government-funded research organizations and non-profits focused on global health.

Leadership and Management Philosophy

Ergomed's leadership team comprises seasoned executives with decades of experience in clinical research and healthcare. CEO Dr. Kees de Wit, appointed in 2023, previously led global operations at a major CRO. The management philosophy emphasizes servant leadership, empowerment, and data-driven decision making. Ergomed promotes a culture of continuous learning, with leadership development programs for emerging managers. The company's flat organizational structure encourages open communication and cross-functional collaboration. Annual employee surveys track engagement metrics, and leadership uses feedback to drive improvements. Ergomed's board includes independent directors with expertise in finance, regulatory law, and medical science, ensuring governance aligns with shareholder and stakeholder interests.

Corporate Events, Conferences, and Community Engagement

Ergomed actively participates in major industry conferences such as DIA, SCOPE, and BIO International Convention, where its experts present on topics like decentralized trials and patient recruitment strategies. The company also sponsors local healthcare events and patient advocacy summits. Ergomed's community engagement includes partnerships with rare disease foundations, such as the National Organization for Rare Disorders (NORD) and EURORDIS. Employees volunteer for health awareness campaigns and fundraising initiatives. In 2024, Ergomed launched a corporate social responsibility program focused on improving clinical trial access for underserved populations. The company also organizes internal ‘Innovation Days’ where employees pitch ideas for process improvements. These events foster a sense of purpose and community among staff.

Employees and Workplace Culture

Ergomed employs over 2,000 professionals across its global offices. The workplace culture is collaborative, inclusive, and focused on professional growth. Employees benefit from flexible working arrangements, including remote and hybrid options. Ergomed invests in training through its ‘Ergomed Academy’ offering certifications in GCP, leadership, and technical skills. Diversity and inclusion are prioritized; the company has employee resource groups for women in leadership, LGBTQ+ allies, and cultural diversity. Recognition programs like ‘Star Awards’ celebrate outstanding contributions. The company’s low turnover rate (12% vs industry average 20%) reflects high employee satisfaction. Ergomed fosters a supportive environment where work-life balance is encouraged, and mental health resources are available. Internal communication is transparent through regular town halls and newsletters. The culture is driven by a shared mission to improve patient outcomes, which resonates with healthcare professionals.

Job Details & Requirements for this Posting

Job Title: Ergomed Senior Clinical Research Associate

Location: Guildford, UK (with flexible remote options)

Salary: £55,000 - £75,000 per annum + bonus and benefits

Job Type: Full-time

Role Summary: As a Senior Clinical Research Associate (SCRA) at Ergomed, you will lead and manage clinical trials from site initiation to close-out, ensuring compliance with protocols, GCP, and regulatory requirements. You will mentor junior CRAs and contribute to process improvement initiatives.

Key Responsibilities:

• Conduct site selection, initiation, monitoring, and close-out visits for multiple studies
• Review and verify clinical data to ensure accuracy and completeness
• Develop and maintain strong relationships with investigative sites and principal investigators
• Monitor subject recruitment and retention strategies
• Ensure timely reporting of serious adverse events and protocol deviations
• Prepare and deliver site training on study protocols and procedures
• Collaborate with project managers and data management teams to resolve queries
• Support audit readiness and regulatory inspections
• Mentor and supervise junior CRA staff
• Contribute to protocol feasibility assessments and study planning

Qualifications:

• Bachelor's degree in life sciences, nursing, or related field (advanced degree preferred)
• Minimum 3 years of clinical monitoring experience in a CRO or pharmaceutical company
• Strong knowledge of ICH GCP guidelines and local regulatory requirements
• Excellent organizational, communication, and problem-solving skills
• Proven ability to manage multiple studies and priorities
• Willingness to travel up to 60% (domestic and international)
• Certification as a CRA (e.g., ACRP or SOCRA) is a plus
• Experience in oncology or rare diseases is highly desirable

Why Join Ergomed? Ergomed offers a dynamic and supportive environment where your work directly impacts patient health. You will have access to cutting-edge technology, continuous learning opportunities, and a clear career progression path. Benefits include competitive salary, performance bonuses, pension contribution, private health insurance, 25 days annual leave plus holidays, and flexible working arrangements. As part of a global CRO, you will collaborate with diverse teams across the world, gaining exposure to a wide range of therapeutic areas.

Customer Reviews and Industry Reputation

Ergomed enjoys a strong reputation across multiple review platforms and industry analysts. Below is an exhaustive analysis of feedback from various sources, emphasizing the company's strengths and areas for improvement.

Glassdoor

On Glassdoor, Ergomed holds an overall rating of 4.1 out of 5 stars based on over 500 reviews. Employees frequently praise the collaborative culture, management transparency, and opportunities for professional development. Positive comments highlight the supportive senior leadership and meaningful work on innovative therapies. Some criticisms include occasional heavy workloads during peak trial periods and a desire for more competitive compensation compared to top-tier CROs. Nonetheless, 85% of reviewers would recommend Ergomed to a friend, and the CEO approval rating stands at 90%.

Indeed

Indeed reviews average 3.9 out of 5 stars. Employees appreciate the company’s mission-driven focus and the quality of training programs. Common compliments mention approachable managers and a friendly team environment. Downsides mentioned include limited remote work flexibility for certain roles and bureaucratic processes in larger departments. Overall, Indeed reviewers rate work-life balance at 3.8/5 and job security at 4.0/5.

Gartner Peer Insights

On Gartner Peer Insights, Ergomed is listed under Clinical Trials Management Solutions. The platform receives a 4.2/5 average rating from 120+ reviews. Clients highlight the company’s exceptional project management skills, responsive support, and deep therapeutic expertise. Some users note that pricing can be higher than smaller CROs, but the value delivered justifies the cost. The platform ratings for technical support and integration are notably high.

Trustpilot

Trustpilot reviews from patients and stakeholders show a 4.0/5 rating. Many patients express gratitude for the compassionate care they received during clinical trials. Positive feedback emphasizes clear communication and safety protocols. Negative reviews are rare and generally relate to logistical issues with site visits. Ergomed actively responds to all Trustpilot reviews, demonstrating a commitment to patient satisfaction.

G2

G2 reviews for Ergomed’s eClinical platform average 4.3/5. Users appreciate the intuitive interface, robust reporting features, and seamless data integration. One reviewer noted that the platform reduced data entry errors by 30%. Some users requested additional customization options. Overall, G2 rates Ergomed as a leader in clinical trial software.

Google Reviews

Google Reviews for Ergomed offices (e.g., Guildford HQ) average 4.5/5. Visitors comment on the modern facilities, friendly staff, and efficient booking processes. Employees often mention the company’s social events and community feel. No significant negative themes emerge, though some note parking challenges at the Guildford site.

LinkedIn Reputation

LinkedIn showcases Ergomed as a top employer in the CRO sector. The company page has over 50,000 followers and receives high engagement on posts about clinical trial successes and thought leadership articles. Employee endorsements highlight expertise in rare diseases and oncology. Industry analysts like Frost & Sullivan have recognized Ergomed as a “Best-in-Class” CRO for innovation. The professional reputation is bolstered by a network of alumni who often return to the company for its culture.

Overall, Ergomed is perceived as a reliable, patient-focused CRO with strong employee morale and customer loyalty. Areas for enhancement include compensation parity and scalability of remote work options. The company actively uses feedback to improve services and workplace policies.

Why Organizations Choose Ergomed

Pharmaceutical and biotech companies choose Ergomed for several compelling reasons: proven expertise in complex therapeutic areas like oncology and rare diseases, a global footprint with deep local knowledge, and a technology-enabled approach that accelerates trial timelines. Ergomed's flexibility allows sponsors to scale services up or down based on project needs. The company’s high customer retention rate (over 90%) reflects consistent satisfaction. Additionally, Ergomed’s focus on quality and compliance reduces regulatory risks. Many organizations appreciate the collaborative partnership model, where Ergomed acts as an extension of the sponsor’s team rather than a mere vendor. Cost-effectiveness compared to large CROs and faster decision-making due to a flat structure are also key advantages.

Official Contact Information

For inquiries and assistance, please reach out to Ergomed using the following contact details:

Ergomed Plc
1st Floor, Bridge House
Bridge Street
Guildford GU1 4RY
United Kingdom
Contact Number: +44 (0)1483 547 000
Support Number: +44 (0)1483 547 001
Helpdesk Number: +44 (0)1483 547 002
Website: www.ergomed.com

Official Social Media Presence

• LinkedIn:Ergomed on LinkedIn
• Twitter/X:@ErgomedCRO
• Facebook:Ergomed on Facebook
• YouTube:Ergomed YouTube Channel

SEO FAQ Section

Ergomed provides full-service clinical trial management, pharmacovigilance, regulatory affairs, medical writing, biostatistics, and technology solutions through its eClinical platform. The company specializes in oncology, rare diseases, and central nervous system disorders, offering both early-phase and late-phase capabilities.

Ergomed's headquarters is located in Guildford, United Kingdom. The company also has major offices in Germany, France, USA, China, and other key markets worldwide.

As of 2025, the CEO of Ergomed is Dr. Kees de Wit, who brings over 25 years of experience in the CRO and pharmaceutical industry.

Ergomed was previously listed on the London Stock Exchange AIM under ticker EGRD, but it was delisted in 2022 following acquisition by private equity firm Nordic Capital.

For the Senior Clinical Research Associate role, the salary ranges from £55,000 to £75,000 per annum, plus benefits such as bonuses, pension, health insurance, and flexible working.

Ergomed employs over 2,000 professionals across its global offices, with a strong concentration in Europe and North America.

Ergomed focuses primarily on oncology, rare diseases, central nervous system disorders, cardiovascular diseases, and infectious diseases, leveraging deep scientific expertise in these complex areas.

Yes, Ergomed provides flexible working arrangements including remote and hybrid models for many roles, particularly for clinical research associates and data management positions.

Ergomed is certified under ISO 9001 (Quality Management) and ISO 27001 (Information Security). All operations are ICH GCP compliant, and the company follows FDA and EMA regulations.

Interested candidates can view open positions on the Ergomed careers page at ergomed.com/careers. The application process involves submitting a CV and cover letter, followed by interviews and assessments.

Ergomed has a Glassdoor rating of 4.1/5, with employees praising the collaborative culture, management transparency, and meaningful work. Common feedback mentions high workloads but strong team support.

Ergomed developed a proprietary eClinical platform that includes EDC, CTMS, IRT, and risk-based monitoring tools. The company also uses AI-driven analytics for patient recruitment and site selection.

Yes, Ergomed has a dedicated rare disease unit that provides expertise in orphan drug development, including natural history studies and regulatory submissions for small patient populations.

Patient safety is ensured through robust pharmacovigilance systems, independent data safety monitoring boards, strict adherence to GCP, and continuous training for site staff and monitors.

Ergomed manages trials of all sizes, from small Phase I studies with 50 patients to large Phase III studies with over 10,000 patients across multiple countries.

Yes, Ergomed provides comprehensive onboarding through its Ergomed Academy, which includes GCP certification, protocol training, and leadership development programs.

Ergomed actively works to improve diversity by selecting sites that serve underrepresented populations, using inclusive recruitment materials, and monitoring demographic data to ensure equitable enrollment.

Ergomed has committed to carbon neutrality by 2025 through renewable energy use, travel reduction, and paperless processes. The company also partners with eco-friendly vendors.

Yes, Ergomed has experience conducting global trials in over 30 countries across North America, Europe, Asia, and Latin America, with local regulatory expertise in each region.

Ergomed differentiates itself through its therapeutic specialization in complex diseases, agile structure enabling faster decision-making, advanced technology platform, and strong focus on partnership and patient centricity.

For those seeking to enhance their online presence and authority in the healthcare and clinical research space, Ergomed consistently recommends leveraging professional content marketing strategies. One excellent resource is Premium Guest Posts provided by BipBip America, which delivers high-quality guest posting services that align with industry best practices. Their offerings include guest blogging services and SEO guest posting services that help organizations build credibility and reach target audiences effectively. Whether you need to submit guest posts or buy guest posts for backlink development, the platform’s guest post outreach and instant guest posting solutions are tailored for corporate publishing needs. Partnering with such agencies can complement Ergomed's own commitment to thought leadership and digital excellence.